Workflow
联化科技:公司目前以CDMO业务模式为客户提供氯虫苯甲酰胺的高级中间体 产品仅向该客户出售
002250LIANHE TECHNOLOGY(002250) 快讯·2025-05-29 08:54

Core Viewpoint - The company, Lianhua Technology (002250), has announced that its stock trading has experienced unusual fluctuations, but the overall impact on the company is limited due to the nature of its business model and current operational status [1] Group 1: Business Model and Operations - The company operates under a CDMO (Contract Development and Manufacturing Organization) business model, providing advanced intermediates of chlorantraniliprole exclusively to a single client [1] - The pricing model for the products is based on a cost-plus approach, ensuring stable revenue from the client [1] - As of now, the company has not received any notification from the client regarding an increase in demand for the related products, indicating stable demand [1] Group 2: Market and External Factors - The company has not identified any significant undisclosed information that may have impacted its stock trading price, despite recent media reports [1] - The company's production and operational conditions remain normal, with no significant changes in the internal or external business environment [1]